These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19602278)

  • 21. Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance.
    Lataillade M; Chiarella J; Kozal MJ
    Antivir Ther; 2007; 12(4):563-70. PubMed ID: 17668566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.
    Myers RE; Pillay D
    J Virol; 2008 Sep; 82(18):9228-35. PubMed ID: 18596095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to HIV-1 integrase inhibitors: A structural perspective.
    Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
    Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity.
    Soares HR; Castro R; Tomás HA; Rodrigues AF; Gomes-Alves P; Bellier B; Klatzmann D; Carrondo MJT; Alves PM; Coroadinha AS
    Vaccine; 2016 Mar; 34(13):1634-1641. PubMed ID: 26795367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.
    Sato K; Aoki J; Misawa N; Daikoku E; Sano K; Tanaka Y; Koyanagi Y
    J Virol; 2008 Jan; 82(2):1021-33. PubMed ID: 17989173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel integrase inhibitors for HIV.
    Prada N; Markowitz M
    Expert Opin Investig Drugs; 2010 Sep; 19(9):1087-98. PubMed ID: 20707594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.
    Charpentier C; Laureillard D; Piketty C; Tisserand P; Batisse D; Karmochkine M; Si-Mohamed A; Weiss L
    AIDS; 2010 Mar; 24(6):867-73. PubMed ID: 20160635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV-1 integrase inhibitor resistance among treatment naïve patients in Gran Canaria, 2017].
    Pena López MJ; Hernández Febles M; Medina Galindo JA; Pérez Jiménez RD
    Rev Esp Quimioter; 2018 Oct; 31(5):459-460. PubMed ID: 30221902
    [No Abstract]   [Full Text] [Related]  

  • 29. Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
    Codoñer FM; Pou C; Thielen A; García F; Delgado R; Dalmau D; Santos JR; Buzón MJ; Martínez-Picado J; Alvarez-Tejado M; Clotet B; Ruiz L; Paredes R
    Antiviral Res; 2010 Dec; 88(3):281-6. PubMed ID: 20883724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.
    Lambelé M; Koppensteiner H; Symeonides M; Roy NH; Chan J; Schindler M; Thali M
    J Virol; 2015 Mar; 89(6):3247-55. PubMed ID: 25568205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion.
    Gordón-Alonso M; Yañez-Mó M; Barreiro O; Alvarez S; Muñoz-Fernández MA; Valenzuela-Fernández A; Sánchez-Madrid F
    J Immunol; 2006 Oct; 177(8):5129-37. PubMed ID: 17015697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct roles for tetraspanins CD9, CD63 and CD81 in the formation of multinucleated giant cells.
    Parthasarathy V; Martin F; Higginbottom A; Murray H; Moseley GW; Read RC; Mal G; Hulme R; Monk PN; Partridge LJ
    Immunology; 2009 Jun; 127(2):237-48. PubMed ID: 19489128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrase Resistance-Associated Mutations on Raltegravir Failure in Western India: A Preliminary Analysis.
    Pujari SN; Gaikwad S; Joshi K; Dabhade D; Sane S; Rao NP; Bele V
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):e42-e45. PubMed ID: 29315113
    [No Abstract]   [Full Text] [Related]  

  • 34. Dolutegravir-Selected HIV-1 Containing the N155H and R263K Resistance Substitutions Does Not Acquire Additional Compensatory Mutations under Drug Pressure That Lead to Higher-Level Resistance and Increased Replicative Capacity.
    Anstett K; Fusco R; Cutillas V; Mesplède T; Wainberg MA
    J Virol; 2015 Oct; 89(20):10482-8. PubMed ID: 26246578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetraspanins are involved in Burkholderia pseudomallei-induced cell-to-cell fusion of phagocytic and non-phagocytic cells.
    Sangsri T; Saiprom N; Tubsuwan A; Monk P; Partridge LJ; Chantratita N
    Sci Rep; 2020 Oct; 10(1):17972. PubMed ID: 33087788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
    Buzón MJ; Dalmau J; Puertas MC; Puig J; Clotet B; Martinez-Picado J
    AIDS; 2010 Jan; 24(1):17-25. PubMed ID: 19770695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors.
    Pham HT; Labrie L; Wijting IEA; Hassounah S; Lok KY; Portna I; Goring ME; Han Y; Lungu C; van der Ende ME; Brenner BG; Boucher CA; Rijnders BJA; van Kampen JJA; Mesplède T; Wainberg MA
    J Infect Dis; 2018 Jul; 218(5):698-706. PubMed ID: 29617824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of CD9 and CD63, two tetraspanin family members expressed in trout B lymphocytes.
    Castro R; Abós B; González L; Aquilino C; Pignatelli J; Tafalla C
    Dev Comp Immunol; 2015 Jul; 51(1):116-25. PubMed ID: 25769915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance.
    Hardy I; Brenner B; Quashie P; Thomas R; Petropoulos C; Huang W; Moisi D; Wainberg MA; Roger M
    J Antimicrob Chemother; 2015 Feb; 70(2):405-11. PubMed ID: 25281399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.